$ALT this just seems to low for a vaccine candidate. Nasal vaccine would be easier to administer and would reach a vast amount of the world easier than injection. The more the big pharma push back the better this will be for the smaller bio companies. This one was trending toward 35 at one point and think it will continue upward with news today. There is an 80.00 price target. We shall see about that but this looks to be an easy triple 45.00 dollars min.
  • 11